Literature DB >> 17462871

Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease.

Marit Granér1, Juhani Kahri, Marjut Varpula, Riitta M Salonen, Kristiina Nyyssönen, Matti Jauhiainen, Markku S Nieminen, Mikko Syvänne, Marja-Riitta Taskinen.   

Abstract

BACKGROUND AND AIMS: Apolipoprotein E (apoE) polymorphism plays a significant role in the development of atherosclerosis and cardiovascular disease. Therefore, the aim of the present study was to examine the association between apoE polymorphism and carotid intima-media thickness (IMT), and severity and extent of coronary artery disease (CAD). METHODS AND
RESULTS: B-mode ultrasound and quantitative coronary angiography (QCA) were used to assess carotid, and coronary artery atherosclerosis in 91 patients with clinically suspected CAD referred for cardiac catheterization. Two apoE phenotype groups were defined: apoE3 (E3/E3) and apoE4 (including E4/E3, E4/E4 phenotypes). Maximum IMT was higher in the apoE4 group than in the apoE3 group (p=0.022). The global atheroma burden index was similarly higher in the apoE4 group than in the apoE3 group (p=0.033). ApoE4 subjects had higher levels of apolipoprotein B (apoB) (p=0.008), triglycerides (p=0.006), remnant lipoprotein-cholesterol (RLP-C) (p=0.023), and lipoprotein(a) [(Lp(a)] (p=0.041) than apoE3 subjects. The mean LDL particle size was smaller in the apoE4 group than in the apoE3 group (p=0.041).
CONCLUSIONS: ApoE polymorphism was associated with both carotid and coronary atherosclerosis. Patients with the apoE4 isoform had an increased carotid IMT and a more severe and extensive CAD than patients with the apoE3 isoform.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462871     DOI: 10.1016/j.numecd.2007.01.003

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  14 in total

1.  Biophysical analysis of progressive C-terminal truncations of human apolipoprotein E4: insights into secondary structure and unfolding properties.

Authors:  Angeliki Chroni; Serapion Pyrpassopoulos; Angelos Thanassoulas; George Nounesis; Vassilis I Zannis; Efstratios Stratikos
Journal:  Biochemistry       Date:  2008-08-09       Impact factor: 3.162

2.  Apolipoprotein A5-1131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescents.

Authors:  D D V Brito; A P Fernandes; K B Gomes; F F Coelho; N G Cruz; A P Sabino; J E Cardoso; P P Figueiredo-Filho; R Diamante; C R Norton; M O Sousa
Journal:  Mol Biol Rep       Date:  2010-12-04       Impact factor: 2.316

Review 3.  Neurovascular Dysfunction in Diverse Communities With Health Disparities-Contributions to Dementia and Alzheimer's Disease.

Authors:  Napatsorn Saiyasit; Evan-Angelo R Butlig; Samantha D Chaney; Miranda K Traylor; Nanako A Hawley; Ryleigh B Randall; Hanna V Bobinger; Carl A Frizell; Franklin Trimm; Errol D Crook; Mike Lin; Benjamin D Hill; Joshua L Keller; Amy R Nelson
Journal:  Front Neurosci       Date:  2022-06-29       Impact factor: 5.152

4.  Allele-dependent thermodynamic and structural perturbations in ApoE variants associated with the correction of dyslipidemia and formation of spherical ApoE-containing HDL particles.

Authors:  Dimitra Georgiadou; Angeliki Chroni; Konstantinos Drosatos; Kyriakos E Kypreos; Vassilis I Zannis; Efstratios Stratikos
Journal:  Atherosclerosis       Date:  2012-11-23       Impact factor: 5.162

5.  White matter hyperintensities are associated with amyloid burden in APOE4 non-carriers.

Authors:  Young Noh; Sang Won Seo; Seun Jeon; Jong Min Lee; Jung-Hyun Kim; Geon Ha Kim; Hanna Cho; Cindy W Yoon; Hee Jin Kim; Byoung Seok Ye; Sung Tae Kim; Yearn Seong Choe; Kyung-Han Lee; Jae Seung Kim; Michael Ewers; Michael W Weiner; Jae-Hong Lee; David J Werring; Dae Ryong Kang; Chang Soo Kim; Duk L Na
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 6.  The role of apolipoprotein E in Alzheimer's disease.

Authors:  Jungsu Kim; Jacob M Basak; David M Holtzman
Journal:  Neuron       Date:  2009-08-13       Impact factor: 17.173

7.  Thermodynamic and structural destabilization of apoE3 by hereditary mutations associated with the development of lipoprotein glomerulopathy.

Authors:  Dimitra Georgiadou; Kostas Stamatakis; Eleni K Efthimiadou; George Kordas; Donald Gantz; Angeliki Chroni; Efstratios Stratikos
Journal:  J Lipid Res       Date:  2012-10-30       Impact factor: 5.922

8.  Protective effects of APOE e2 against disease progression in subcortical vascular mild cognitive impairment patients: A three-year longitudinal study.

Authors:  Yeo Jin Kim; Sang Won Seo; Seong Beom Park; Jin Ju Yang; Jin San Lee; Juyoun Lee; Young Kyoung Jang; Sung Tae Kim; Kyung-Han Lee; Jong Min Lee; Jae-Hong Lee; Jae Seung Kim; Duk L Na; Hee Jin Kim
Journal:  Sci Rep       Date:  2017-05-15       Impact factor: 4.379

9.  Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy.

Authors:  Michael Tran Duong; Ilya M Nasrallah; David A Wolk; Catherine C Y Chang; Ta-Yuan Chang
Journal:  Front Aging Neurosci       Date:  2021-03-25       Impact factor: 5.750

10.  The association study of Apolipoprotein E polymorphisms and chronic obstructive pulmonary disease in the Chinese population: A case-control study.

Authors:  Yuan Zhang; Xiao-Hui Li; Yu-Tian Zhou; Lu Xiang; Meng Xiao; Jian-Shu Guo; Jing-Wei Zhang; Guo Chen
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.